Physitrack PLC (PTRK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Physitrack PLC (PTRK) has a cash flow conversion efficiency ratio of 0.072x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr717.06K ≈ $77.17K USD) by net assets (Skr9.96 Million ≈ $1.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PTRK net asset quality score to measure how much of total assets are equity-financed.
Physitrack PLC - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Physitrack PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Physitrack PLC to evaluate the quality of earnings relative to operating cash generation.
Physitrack PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Physitrack PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ESV Inc
KQ:223310
|
-0.381x |
|
Euromedis Groupe SA
PA:ALEMG
|
0.048x |
|
MSCM Holdings Bhd
KLSE:0041
|
-0.048x |
|
Salona Cotspin Limited
NSE:SALONA
|
0.248x |
|
Image Resources NL
AU:IMA
|
0.024x |
|
Priceworth International Bhd
KLSE:7123
|
-0.039x |
|
Minnova Corp
V:MCI
|
0.884x |
|
Argenica Therapeutics Ltd
AU:AGN
|
-1.602x |
Annual Cash Flow Conversion Efficiency for Physitrack PLC (2017–2025)
The table below shows the annual cash flow conversion efficiency of Physitrack PLC from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see PTRK market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-11-30 | Skr9.92 Million ≈ $1.07 Million |
Skr3.88 Million ≈ $417.72K |
0.391x | +139.87% |
| 2024-11-30 | Skr19.17 Million ≈ $2.06 Million |
Skr3.13 Million ≈ $336.50K |
0.163x | +57.55% |
| 2023-11-30 | Skr25.57 Million ≈ $2.75 Million |
Skr2.65 Million ≈ $284.98K |
0.104x | +59.58% |
| 2022-11-30 | Skr22.37 Million ≈ $2.41 Million |
Skr1.45 Million ≈ $156.22K |
0.065x | +181.76% |
| 2021-11-30 | Skr28.65 Million ≈ $3.08 Million |
Skr659.81K ≈ $71.01K |
0.023x | -94.12% |
| 2020-11-30 | Skr5.19 Million ≈ $558.20K |
Skr2.03 Million ≈ $218.73K |
0.392x | -19.70% |
| 2019-11-30 | Skr1.03 Million ≈ $110.46K |
Skr500.89K ≈ $53.90K |
0.488x | -17.54% |
| 2018-11-30 | Skr1.19 Million ≈ $128.31K |
Skr705.60K ≈ $75.93K |
0.592x | +45.95% |
| 2017-11-30 | Skr1.35 Million ≈ $145.78K |
Skr549.27K ≈ $59.11K |
0.405x | -- |
About Physitrack PLC
Physitrack PLC, together with its subsidiaries, provides digital healthcare solutions in the United Kingdom, Europe, North America, and internationally. It operates through two segments, Lifecare and Wellness. The company offers Physitrack, a remote therapeutic monitoring platform that provides a suite of tools for exercise program prescription, patient-reported adherence and tracking, and telehe… Read more